Neurobo Pharmaceuticals Inc (NRBO) Annual Income Statement (USD)
NRBO Quarterly Financials (USD)
Frequently Asked Questions About Neurobo Pharmaceuticals Inc (NRBO) Stock
Neurobo Pharmaceuticals Inc's (NRBO) last reported annual revenue was USD 7000.00.
Neurobo Pharmaceuticals Inc's (NRBO) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Neurobo Pharmaceuticals Inc's(NRBO) is not profitable as of its last reported annual financials.
The net profit margin for Neurobo Pharmaceuticals Inc's(NRBO) from its laster reported year is -178142.86%
The return on equity (ROE) for Neurobo Pharmaceuticals Inc's(NRBO) from its last reported annual financials is : -160.76%
The return on assets (ROA) for Neurobo Pharmaceuticals Inc's(NRBO) from its last reported annual financials is : -74.35%
The return on invested capital (ROIC) for Neurobo Pharmaceuticals Inc's(NRBO) from its last reported annual financials is : -82.66%
The Debt to Equity ratio for Neurobo Pharmaceuticals Inc's(NRBO) from its last reported annual financials is : 0.00%
The dividend yield for Neurobo Pharmaceuticals Inc's(NRBO) from its laster reported year is 0.00%
Neurobo Pharmaceuticals Inc's(NRBO) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for NRBO !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
